Objective To determine whether a treatment strategy based on structured ultrasound
assessment would lead to improved outcomes in rheumatoid arthritis, compared with a …

Objectives To investigate whether baseline disease activity levels and responses in patients
with rheumatoid arthritis (RA) changed during the period 2000–2010. Methods Data were …

Objectives To compare the presentation of seropositive and seronegative early rheumatoid
arthritis (RA) in disease-modifying antirheumatic drug (DMARD)-naïve patients classified …

Objectives Calprotectin is an inflammatory marker of interest in rheumatoid arthritis (RA). We
evaluated whether the level of calprotectin was associated with disease activity, and if it was …

Objectives Recent studies suggest that implementation of the 2010 American College of
Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria …

Importance Sustained remission has become an achievable goal for patients with
rheumatoid arthritis (RA) receiving conventional synthetic disease-modifying antirheumatic …

Objective To explore associations between remission, based on clinical and ultrasound
definitions, and future good radiographic and physical outcome in early rheumatoid arthritis …

Background Tapering of disease-modifying antirheumatic drugs (DMARDs) to drug-free
remission is an attractive treatment goal for patients with rheumatoid arthritis, although long …

Background: Differences in DNA methylation have been reported in B and T lymphocyte
populations, including CD4+ T cells, isolated from rheumatoid arthritis (RA) patients when …

Objectives To investigate if inflammation detected by MRI or ultrasound at rheumatoid
arthritis (RA) onset is predictive of erosive progression or poor response to methotrexate …